170 related articles for article (PubMed ID: 24462558)
1. Safety of discontinuation of anti-coagulation in patients with continuous-flow left ventricular assist devices.
Kamdar F; Eckman P; John R
J Heart Lung Transplant; 2014 Mar; 33(3):316-8. PubMed ID: 24462558
[No Abstract] [Full Text] [Related]
2. Activated partial thromboplastin time overestimates anti-coagulation in left ventricular assist device patients.
McIlvennan CK; Page RL; Ambardekar AV; Brieke A; Lindenfeld J
J Heart Lung Transplant; 2014 Dec; 33(12):1312-4. PubMed ID: 25443872
[No Abstract] [Full Text] [Related]
3. Low-molecular-weight heparin for anti-coagulation after left ventricular assist device implantation.
Sandner SE; Riebandt J; Haberl T; Mahr S; Rajek A; Schima H; Wieselthaler GM; Laufer G; Zimpfer D
J Heart Lung Transplant; 2014 Jan; 33(1):88-93. PubMed ID: 24239003
[TBL] [Abstract][Full Text] [Related]
4. Antiplatelet Therapy and Adverse Hematologic Events During Heart Mate II Support.
Saeed O; Shah A; Kargoli F; Madan S; Levin AP; Patel SR; Jermyn R; Guerrero C; Nguyen J; Sims DB; Shin J; D'Alessandro D; Goldstein DJ; Jorde UP
Circ Heart Fail; 2016 Jan; 9(1):e002296. PubMed ID: 26721914
[TBL] [Abstract][Full Text] [Related]
5. Gastrointestinal bleeding and subsequent risk of thromboembolic events during support with a left ventricular assist device.
Stulak JM; Lee D; Haft JW; Romano MA; Cowger JA; Park SJ; Aaronson KD; Pagani FD
J Heart Lung Transplant; 2014 Jan; 33(1):60-4. PubMed ID: 24021944
[TBL] [Abstract][Full Text] [Related]
6. Device thrombosis in HeartMate II continuous-flow left ventricular assist devices: a multifactorial phenomenon.
Uriel N; Han J; Morrison KA; Nahumi N; Yuzefpolskaya M; Garan AR; Duong J; Colombo PC; Takayama H; Thomas S; Naka Y; Jorde UP
J Heart Lung Transplant; 2014 Jan; 33(1):51-9. PubMed ID: 24290832
[TBL] [Abstract][Full Text] [Related]
7. An analysis of pump thrombus events in patients in the HeartWare ADVANCE bridge to transplant and continued access protocol trial.
Najjar SS; Slaughter MS; Pagani FD; Starling RC; McGee EC; Eckman P; Tatooles AJ; Moazami N; Kormos RL; Hathaway DR; Najarian KB; Bhat G; Aaronson KD; Boyce SW;
J Heart Lung Transplant; 2014 Jan; 33(1):23-34. PubMed ID: 24418731
[TBL] [Abstract][Full Text] [Related]
8. Assessment of long-term anticoagulation in patients with a continuous-flow left-ventricular assist device: a pilot study.
Jennings D; McDonnell J; Schillig J
J Thorac Cardiovasc Surg; 2011 Jul; 142(1):e1-2. PubMed ID: 21529846
[No Abstract] [Full Text] [Related]
9. Anticoagulation management of left ventricular assist devices.
Connors JM
Am J Hematol; 2015 Feb; 90(2):175-8. PubMed ID: 25163820
[No Abstract] [Full Text] [Related]
10. Aortic valve opening and thrombotic events with continuous-flow left ventricular assist devices.
Saeed O; Maybaum S; Alessandro DD; Goldstein DJ; Patel SR
J Heart Lung Transplant; 2014 Jan; 33(1):109-12. PubMed ID: 23937883
[No Abstract] [Full Text] [Related]
11. Low thromboembolic risk for patients with the Heartmate II left ventricular assist device.
John R; Kamdar F; Liao K; Colvin-Adams M; Miller L; Joyce L; Boyle A
J Thorac Cardiovasc Surg; 2008 Nov; 136(5):1318-23. PubMed ID: 19026822
[TBL] [Abstract][Full Text] [Related]
12. Anticoagulation with apixaban in a patient with a left ventricular assist device and gastrointestinal bleeding: A viable alternative to warfarin?
Pollari F; Fischlein T; Fittkau M; Santarpino G
J Thorac Cardiovasc Surg; 2016 Apr; 151(4):e79-81. PubMed ID: 26586358
[No Abstract] [Full Text] [Related]
13. Long-Term Discontinuation of Oral Anticoagulation Therapy During HeartMate 3 Left Ventricular Assist Device Support.
Hergesell V; Dapunt O; Spiliopoulos S
Artif Organs; 2019 Mar; 43(3):320-321. PubMed ID: 30548270
[No Abstract] [Full Text] [Related]
14. Low thromboembolism and pump thrombosis with the HeartMate II left ventricular assist device: analysis of outpatient anti-coagulation.
Boyle AJ; Russell SD; Teuteberg JJ; Slaughter MS; Moazami N; Pagani FD; Frazier OH; Heatley G; Farrar DJ; John R
J Heart Lung Transplant; 2009 Sep; 28(9):881-7. PubMed ID: 19716039
[TBL] [Abstract][Full Text] [Related]
15. Post-operative heparin may not be required for transitioning patients with a HeartMate II left ventricular assist system to long-term warfarin therapy.
Slaughter MS; Naka Y; John R; Boyle A; Conte JV; Russell SD; Aaronson KD; Sundareswaran KS; Farrar DJ; Pagani FD
J Heart Lung Transplant; 2010 Jun; 29(6):616-24. PubMed ID: 20400335
[TBL] [Abstract][Full Text] [Related]
16. Warfarin and Aspirin Versus Warfarin Alone for Prevention of Embolic Events in Patients with a HeartMate II Left Ventricular Assist Device.
Van Tuyl JS; Hollis IB; Alburikan KA; Tran RH; Murray BP; Rodgers JE; Katz JN; Sheridan BC
ASAIO J; 2017; 63(6):731-735. PubMed ID: 28319521
[TBL] [Abstract][Full Text] [Related]
17. Increased incidence of gastrointestinal bleeding following implantation of the HeartMate II LVAD.
Stern DR; Kazam J; Edwards P; Maybaum S; Bello RA; D'Alessandro DA; Goldstein DJ
J Card Surg; 2010 May; 25(3):352-6. PubMed ID: 20331479
[TBL] [Abstract][Full Text] [Related]
18. Arteriovenous malformation and gastrointestinal bleeding in patients with the HeartMate II left ventricular assist device.
Demirozu ZT; Radovancevic R; Hochman LF; Gregoric ID; Letsou GV; Kar B; Bogaev RC; Frazier OH
J Heart Lung Transplant; 2011 Aug; 30(8):849-53. PubMed ID: 21530318
[TBL] [Abstract][Full Text] [Related]
19. Long-term discontinuation of antithrombotic therapy in patients with HeartMate II continuous-flow left ventricular assist device support.
Schurr JW; Seifert FC; McLarty AJ
Int J Artif Organs; 2019 Dec; 42(12):770-774. PubMed ID: 31298625
[TBL] [Abstract][Full Text] [Related]
20. Gastrointestinal bleeding with the HeartMate II left ventricular assist device.
Morgan JA; Paone G; Nemeh HW; Henry SE; Patel R; Vavra J; Williams CT; Lanfear DE; Tita C; Brewer RJ
J Heart Lung Transplant; 2012 Jul; 31(7):715-8. PubMed ID: 22425231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
